| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
18,108 |
11,896 |
$3.75M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
28,905 |
23,839 |
$1.42M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
23,034 |
14,772 |
$793K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
5,578 |
4,904 |
$792K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
945 |
765 |
$553K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
10,933 |
7,094 |
$519K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,541 |
3,124 |
$430K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,443 |
12,874 |
$332K |
| 96367 |
|
7,645 |
5,173 |
$320K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
65,684 |
45,069 |
$284K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
2,852 |
1,779 |
$274K |
| 80053 |
Comprehensive metabolic panel |
44,849 |
34,116 |
$274K |
| 99215 |
Prolong outpt/office vis |
3,080 |
2,396 |
$247K |
| 96417 |
|
1,802 |
1,187 |
$178K |
| J1626 |
Injection, granisetron hydrochloride, 100 mcg |
1,692 |
1,060 |
$139K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,546 |
1,072 |
$95K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,809 |
1,910 |
$86K |
| J1453 |
Injection, fosaprepitant, 1 mg |
488 |
324 |
$64K |
| J9271 |
Injection, pembrolizumab, 1 mg |
17 |
12 |
$61K |
| 82728 |
|
9,400 |
8,152 |
$61K |
| 82378 |
|
4,630 |
3,917 |
$52K |
| J9045 |
Injection, carboplatin, 50 mg |
151 |
92 |
$46K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
666 |
417 |
$39K |
| Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg |
24 |
12 |
$30K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
775 |
505 |
$26K |
| 96415 |
|
580 |
393 |
$25K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
740 |
491 |
$22K |
| 83615 |
|
5,166 |
4,268 |
$19K |
| 36415 |
Collection of venous blood by venipuncture |
32,897 |
25,247 |
$13K |
| 82607 |
|
1,835 |
1,602 |
$13K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
46 |
36 |
$13K |
| J0185 |
Injection, aprepitant, 1 mg |
179 |
95 |
$11K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
6,567 |
4,281 |
$11K |
| 82746 |
|
1,557 |
1,361 |
$11K |
| 51798 |
|
1,789 |
1,465 |
$9K |
| 83550 |
|
1,745 |
1,504 |
$8K |
| 84550 |
|
2,477 |
2,042 |
$7K |
| 83540 |
|
1,757 |
1,511 |
$6K |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
354 |
238 |
$6K |
| 86300 |
|
399 |
351 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
81 |
64 |
$5K |
| 99233 |
Prolong inpt eval add15 m |
115 |
38 |
$4K |
| 78306 |
|
67 |
55 |
$4K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
143 |
61 |
$3K |
| 82565 |
|
1,019 |
926 |
$3K |
| 76642 |
|
63 |
50 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
44 |
25 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
304 |
224 |
$2K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
27 |
25 |
$2K |
| 96411 |
|
22 |
13 |
$1K |
| J3490 |
Unclassified drugs |
1,585 |
969 |
$1K |
| 84165 |
|
233 |
191 |
$1K |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
80 |
67 |
$1K |
| 86334 |
|
113 |
92 |
$1K |
| J2704 |
Injection, propofol, 10 mg |
181 |
117 |
$1K |
| J1750 |
Injection, iron dextran, 50 mg |
15 |
12 |
$857.50 |
| 82784 |
|
128 |
109 |
$774.17 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
27 |
25 |
$731.40 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,598 |
2,461 |
$727.77 |
| G0008 |
Administration of influenza virus vaccine |
12 |
12 |
$430.99 |
| 83735 |
|
93 |
51 |
$411.05 |
| T1502 |
Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit |
33 |
26 |
$373.76 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
49 |
13 |
$359.86 |
| 90674 |
|
28 |
26 |
$353.64 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
62 |
51 |
$337.50 |
| S0028 |
Injection, famotidine, 20 mg |
430 |
257 |
$296.99 |
| 81000 |
|
344 |
273 |
$292.62 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
16 |
13 |
$282.51 |
| 81003 |
|
1,727 |
1,405 |
$240.04 |
| J9267 |
Injection, paclitaxel, 1 mg |
22 |
14 |
$201.60 |
| J9190 |
Injection, fluorouracil, 500 mg |
38 |
24 |
$121.50 |
| 76937 |
|
13 |
12 |
$113.88 |
| 85045 |
|
21 |
16 |
$93.36 |
| 82668 |
|
14 |
12 |
$80.52 |
| 84436 |
|
21 |
14 |
$44.50 |
| 85652 |
|
15 |
12 |
$31.40 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
46 |
37 |
$7.74 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
21 |
12 |
$0.00 |